Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2026-09-02 18:43:59 ET · period of report 2026-09-01 · accession 0001193125-26-380595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 18:43 | 2026-09-01 | ANTX | FitzPatrick Margaret M | Dir | P - Purchase | $5.53 | +2,098 | 10.7K | +24% | +$11.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | P | A | 2,098 | $5.53 | 10,708 | D | — | — |